# Filing Detail

Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001140361-22-025938
Filing Date
2022-07-13
Accepted
2022-07-13 17:05:54
Documents
10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRER14A | ny20004078x14_prer14a.htm | PRER14A | 6960836
2 |  | logo_centerviewpartnersv2.jpg | GRAPHIC | 20936
3 |  | logo_neogen.jpg | GRAPHIC | 26380
4 |  | ny20004078x14_flowchart01.jpg | GRAPHIC | 61577
5 |  | ny20004078x14_flowchart02.jpg | GRAPHIC | 97606
6 |  | ny20004078x14_flowchart03.jpg | GRAPHIC | 99702
7 |  | ny20004078x14_pc01.jpg | GRAPHIC | 732989
8 |  | ny20004078x14_pc02.jpg | GRAPHIC | 689384
9 |  | ny20004078x14_piechart01.jpg | GRAPHIC | 64155
10 |  | ny20004078x14_piechart02.jpg | GRAPHIC | 47573
| Complete submission text file | 0001140361-22-025938.txt |  | 9494559

Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: PRER14A | Act: 34 | File No.: 000-17988 | Film No.: 221081573
SIC: 2835 In Vitro & In Vivo Diagnostic Substances